BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 22278637)

  • 1. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.
    Lakner AM; Steuerwald NM; Walling TL; Ghosh S; Li T; McKillop IH; Russo MW; Bonkovsky HL; Schrum LW
    Hepatology; 2012 Jul; 56(1):300-10. PubMed ID: 22278637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-19b Expression in Human Biliary Atresia Specimens and Its Role in BA-Related Fibrosis.
    Zhao D; Luo Y; Xia Y; Zhang JJ; Xia Q
    Dig Dis Sci; 2017 Mar; 62(3):689-698. PubMed ID: 28083843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huangqi Decoction, a compound Chinese herbal medicine, inhibits the proliferation and activation of hepatic stellate cells by regulating the long noncoding RNA-C18orf26-1/microRNA-663a/transforming growth factor-β axis.
    Dong BS; Liu FQ; Yang WN; Li XD; Shi MJ; Li MR; Yan XL; Zhang H
    J Integr Med; 2023 Jan; 21(1):47-61. PubMed ID: 36456413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
    Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
    Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
    Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L
    Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition.
    Zheng J; Wang W; Yu F; Dong P; Chen B; Zhou MT
    Cell Physiol Biochem; 2018; 46(1):82-92. PubMed ID: 29587268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-Associated Virus Serotype 2 Vector-Mediated Reintroduction of microRNA-19b Attenuates Hepatic Fibrosis.
    Brandon-Warner E; Benbow JH; Swet JH; Feilen NA; Culberson CR; McKillop IH; deLemos AS; Russo MW; Schrum LW
    Hum Gene Ther; 2018 Jun; 29(6):674-686. PubMed ID: 29281894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Epigenetically-Regulated microRNA-378a Targets TGF-β2 in TGF-β1-Treated Hepatic Stellate Cells.
    Yu F; Yang J; Huang K; Pan X; Chen B; Dong P; Zheng J
    Cell Physiol Biochem; 2016; 40(1-2):183-194. PubMed ID: 27855367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis.
    Xie X; Dou CY; Zhou Y; Zhou Q; Tang HB
    Dig Dis Sci; 2021 Jun; 66(6):1928-1939. PubMed ID: 32648079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-142-3p blocks TGF-β-induced activation of hepatic stellate cells through targeting TGFβRI.
    Yang X; Dan X; Men R; Ma L; Wen M; Peng Y; Yang L
    Life Sci; 2017 Oct; 187():22-30. PubMed ID: 28823564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling.
    Wu SM; Li TH; Yun H; Ai HW; Zhang KH
    Yonsei Med J; 2019 Jun; 60(6):561-569. PubMed ID: 31124340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hes1, an important gene for activation of hepatic stellate cells, is regulated by Notch1 and TGF-β/BMP signaling.
    Zhang K; Zhang YQ; Ai WB; Hu QT; Zhang QJ; Wan LY; Wang XL; Liu CB; Wu JF
    World J Gastroenterol; 2015 Jan; 21(3):878-87. PubMed ID: 25624721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
    Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
    Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of liver cirrhosis achieved by inhibitory effect of miR-454 on hepatic stellate cells activation and proliferation via Wnt10a.
    Wang YZ; Zhang W; Wang YH; Fu XL; Xue CQ
    J Biochem; 2019 Apr; 165(4):361-367. PubMed ID: 30535384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymosin β4 suppresses CCl
    Li H; Li Q; Zhang X; Zheng X; Zhang Q; Hao Z
    J Gene Med; 2018 Sep; 20(9):e3043. PubMed ID: 29972714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-30c and miR-193 are a part of the TGF-β-dependent regulatory network controlling extracellular matrix genes in liver fibrosis.
    Roy S; Benz F; Vargas Cardenas D; Vucur M; Gautheron J; Schneider A; Hellerbrand C; Pottier N; Alder J; Tacke F; Trautwein C; Roderburg C; Luedde T
    J Dig Dis; 2015 Sep; 16(9):513-24. PubMed ID: 26120970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligustrazine Attenuates Liver Fibrosis by Targeting miR-145 Mediated Transforming Growth Factor-
    Qiu JL; Zhang GF; Chai YN; Han XY; Zheng HT; Li XF; Duan F; Chen LY
    J Pharmacol Exp Ther; 2022 Jun; 381(3):257-265. PubMed ID: 35398813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-30 Protects Against Carbon Tetrachloride-induced Liver Fibrosis by Attenuating Transforming Growth Factor Beta Signaling in Hepatic Stellate Cells.
    Tu X; Zheng X; Li H; Cao Z; Chang H; Luan S; Zhu J; Chen J; Zang Y; Zhang J
    Toxicol Sci; 2015 Jul; 146(1):157-69. PubMed ID: 25912033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis.
    Fu N; Zhao SX; Kong LB; Du JH; Ren WG; Han F; Zhang QS; Li WC; Cui P; Wang RQ; Zhang YG; Nan YM
    Gene; 2017 Jun; 618():1-7. PubMed ID: 28302418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.